23-Aug-15 Emerging-market sales for the big pharmaceuticals firms increased by about 5.5% year over year in the second quarter, well below the 9% average of the prior four quarters. Macroeconomic pressures are increasing. Weaker currencies hurt sales, a factor put into clear focus by China’s devaluation of the yuan. [image: Nai 500]

21-Aug-15 The Indian government plans to increase public investment in health from 1.04% of GDP to 2.5% by 2020. Approximately, 70% of the expenditure will be dedicated to primary health care. [image: The Richest]

26-Aug-15 China is aiming to control “wildly” growing stem cell therapy, issuing its first regulation covering the largely controversial medical procedure. “Only eligible hospitals can work with stem cells in clinical trials for research and there must not be fees or advertising,” said the National Health and Family Planning Commission. [image: Liu Haifeng / Xinhua Press / Corbis]

19-Aug-15 A new guideline allows foreign drugs to undergo clinical trials in their home country and in China at the same pace, speeding up approval procedures for new drugs that are badly needed in China. Clinical trials of new foreign drugs in China normally lag behind those in the home country. [image: Alamy / Daily Mail]

18-Aug-15 The Philippines government has completed the construction and expansion of 68 health facilities in Central Luzon. 32 of the facilities are located in Bulacan; 15 in Pampanga; 2 each in Aurora, Tarlac, and Zambales; and 1 each in Bataan and Nueva Ecija. The program is intended to revitalize primary health care and upgrade hospitals to decongest end-referral hospitals. [image: Hospital Directory Asia]